---
title: "The first insurance company's third-quarter report \"preview\" is out: NCI \"brings good news\""
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/260966237.md"
description: "\"Portfolio Statement\" Affects the Overall Situation"
datetime: "2025-10-14T01:33:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/260966237.md)
  - [en](https://longbridge.com/en/news/260966237.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/260966237.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/260966237.md) | [English](https://longbridge.com/en/news/260966237.md)


# The first insurance company's third-quarter report "preview" is out: NCI "brings good news"

On the evening of October 13, NCI "took the lead" in disclosing its third-quarter earnings "forecast."

Preliminary estimates before the official announcement of the third-quarter report indicate that this life insurance giant is expected to see its net profit attributable to shareholders increase by RMB 9.306 billion to RMB 13.442 billion in the first three quarters of this year, a year-on-year growth of 45% to 65%.

In light of the "good news" performance, NCI revealed in the announcement that the company's investment income in the first three quarters of this year continues to grow significantly year-on-year on the basis of last year's high growth, thus achieving a substantial year-on-year increase in net profit for the first three quarters of 2025.

It is evident that the "investment portfolio bill" of large insurance companies affects the performance of the entire financial report.

## **Net Profit in the First Three Quarters Expected to Increase by 45%-65%**

NCI disclosed that after preliminary calculations, the net profit attributable to shareholders for the first three quarters of 2025 is expected to be between RMB 29.986 billion and RMB 34.122 billion.

The aforementioned net profit figures for the first three quarters are **expected to increase by RMB 9.306 billion to RMB 13.442 billion compared to the same period in 2024, representing a year-on-year growth of 45% to 65%.**

This announcement also disclosed another financial indicator—the net profit attributable to shareholders after deducting non-recurring gains and losses, which is expected to be between RMB 28.998 billion and RMB 33.141 billion for the first three quarters of 2025. Compared to the same period in 2024, it is expected to increase by RMB 8.285 billion to RMB 12.428 billion, representing a year-on-year growth of 40% to 60%.

Generally speaking, the core of this indicator lies in "deducting non-recurring gains and losses," which excludes one-time or incidental gains or losses, providing a more accurate reflection of the company's ongoing profitability and operational efficiency.

It is worth noting that the above forecast data is only preliminary calculated data, and the specific accurate financial data will be based on the officially disclosed third-quarter report for 2025.

## **Behind the Performance Increase: Significant Growth in Investment Income**

NCI disclosed the main reasons for the expected growth in performance for the first three quarters of 2025 in the announcement:

NCI also pointed out that, firstly, the company focuses on the growth of insurance business value and quality improvement, upgrading its foundational projects, strengthening institutional operations, and enhancing the self-management capabilities of its teams, **fully managing the insurance liability side in areas such as products, services, teams, ecology, technology, and operations, and accelerating the transformation of dividend insurance.**

Secondly, it fully leverages the advantages of insurance funds as "long-term capital, patient capital, and strategic capital," **actively responding to the call for insurance funds to enter the market, continuously optimizing the asset allocation structure**, increasing the allocation of high-quality underlying assets that can withstand low-interest rate challenges, and solidifying the foundation for long-term returns.

Thirdly, **the stabilization and improvement of the Chinese capital market in the first three quarters has led to a significant year-on-year increase in the company's investment income for the first three quarters of 2025, building on last year's high growth**, thereby achieving a substantial year-on-year increase in net profit for the first three quarters of 2025

### 相關股票

- [NCI (601336.CN)](https://longbridge.com/zh-HK/quote/601336.CN.md)
- [NCI (01336.HK)](https://longbridge.com/zh-HK/quote/01336.HK.md)

## 相關資訊與研究

- [A Look At China Life Insurance (SEHK:2628) Valuation After Strong 2025 Earnings And Proposed Final Dividend](https://longbridge.com/zh-HK/news/281251717.md)
- [AIA Group Tightens Audit Governance With Updated Committee Mandate](https://longbridge.com/zh-HK/news/281183930.md)
- [Ping An targets doubling valuation as 60% of claims go automated](https://longbridge.com/zh-HK/news/281231549.md)
- [Junshi Biosciences Chairman Completes RMB100 Million Shareholding Increase](https://longbridge.com/zh-HK/news/281231901.md)
- [Xinhua Pharma Becomes Marketing Authorization Holder of Dental Drug After Regulatory Nod](https://longbridge.com/zh-HK/news/281343251.md)